Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00395-017-0657-7.

Title:
The role of PI3Kα isoform in cardioprotection | Basic Research in Cardiology
Description:
Ischemic preconditioning (IPC) limits myocardial infarct size through the activation of the PI3K–Akt signal cascade; however, little is known about the roles of individual PI3K isoforms in cardioprotection. We aimed, therefore, to elucidate the role of the PI3Kα isoform in cardioprotection Pharmacological PI3Kα inhibition was assessed in isolated-perfused mouse hearts subjected to ischemia/reperfusion injury (IRI), either during the IPC procedure or at reperfusion. PI3Kα inhibition abrogated the IPC-induced protective effect at reperfusion, but not when given only during the IPC protocol. These results were confirmed in an in vivo model. Moreover, pharmacological PI3Kα activation by insulin at reperfusion was sufficient to confer cardioprotection against IRI. In addition, PI3Kα was shown to be expressed and activated in mouse cardiomyocytes, mouse cardiac endothelial cells, as well as in mouse and human heart tissue. Furthermore, PI3Kα was shown to mediate its effect though the inhibition of mitochondrial permeability transition pore opening. In conclusion, PI3Kα activity is required during the early reperfusion phase to reduce myocardial infarct size. This suggests that strategies specifically enhancing the α isoform of PI3K at reperfusion promote tissue salvage and as such, and could provide a direct target for clinical treatment of IRI.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Health & Fitness
  • Technology & Computing

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't figure out the monetization strategy.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {🔍}

pikα, ipc, pubmed, article, reperfusion, google, scholar, insulin, mouse, heart, cas, myocardial, activation, tissue, gdcg, cardioprotection, role, human, akt, cardiomyocytes, preconditioning, pik, cells, min, protein, size, effect, cardiac, mptp, inhibition, protocol, cell, kinase, control, fig, ischemic, signalling, inhibitors, yellon, vivo, model, protection, infarct, endothelial, phosphorylation, activator, central, expression, iri, results,

Topics {✒️}

bio-rad mini trans-blot patient baseline characteristics article download pdf pro-survival signalling cascades mapping pro-survival cascades mouse langendorff-perfused hearts potassium–glucose–insulin solution glucose-insulin-potassium infusion intravenous glucose-insulin-potassium mann–whitney test depending parametric kruskal–wallis test ischaemic/reperfused heart—druggable related subjects 60 mg/kg sodium pentobarbitone university college london broad-spectrum pi3k inhibitors cardiac ischemia/reperfusion injury treat ischemia/reperfusion injury global ischemia-reperfusion injury pan-specific pi3k inhibitors full access pi3k isoform-specific agents involves gpcr-ligand activation baseline characteristics reactive oxygen species phosphate-buffered saline injected krebs–henseleit buffer hepes-based recording buffer reduced phosphoinositide 3-kinase acute myocardial infarction myocardial infarct size compensatory signalling pathways jonassen ak attenuate infarct size pi3kα-induced akt phosphorylation ros-mediated mptp model distinct pi3kα-selective inhibitors tyrosine kinase receptor rat hearts subjected phospho-threonine308 akt levels isoform-specific pi3k inhibitors privacy choices/manage cookies end-effector mechanism mediating promote myocardial salvage left ventricular tissue reporting animal research ros-stimulated mptp opening insulin-induced pi3kα activation article rossello cell signalling technology

Questions {❓}

  • Heusch G, Rassaf T (2016) Time to give up on cardioprotection?
  • Kleinbongard P, Heusch G (2015) Extracellular signalling molecules in the ischaemic/reperfused heart—druggable and translatable for cardioprotection?
  • Knight ZA, Gonzalez B, Feldman ME, Zunder ER, Goldenberg DD, Williams O, Loewith R, Stokoe D, Balla A, Toth B, Balla T, Weiss WA, Williams RL, Shokat KM (2006) A pharmacological map of the PI3-K family defines a role for p110?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:The role of PI3Kα isoform in cardioprotection
         description:Ischemic preconditioning (IPC) limits myocardial infarct size through the activation of the PI3K–Akt signal cascade; however, little is known about the roles of individual PI3K isoforms in cardioprotection. We aimed, therefore, to elucidate the role of the PI3Kα isoform in cardioprotection Pharmacological PI3Kα inhibition was assessed in isolated-perfused mouse hearts subjected to ischemia/reperfusion injury (IRI), either during the IPC procedure or at reperfusion. PI3Kα inhibition abrogated the IPC-induced protective effect at reperfusion, but not when given only during the IPC protocol. These results were confirmed in an in vivo model. Moreover, pharmacological PI3Kα activation by insulin at reperfusion was sufficient to confer cardioprotection against IRI. In addition, PI3Kα was shown to be expressed and activated in mouse cardiomyocytes, mouse cardiac endothelial cells, as well as in mouse and human heart tissue. Furthermore, PI3Kα was shown to mediate its effect though the inhibition of mitochondrial permeability transition pore opening. In conclusion, PI3Kα activity is required during the early reperfusion phase to reduce myocardial infarct size. This suggests that strategies specifically enhancing the α isoform of PI3K at reperfusion promote tissue salvage and as such, and could provide a direct target for clinical treatment of IRI.
         datePublished:2017-10-17T00:00:00Z
         dateModified:2017-10-17T00:00:00Z
         pageStart:1
         pageEnd:17
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1007/s00395-017-0657-7
         keywords:
            Cardioprotection
            Phosphoinositide 3-kinase
            Ischemic preconditioning
            Ischemia/reperfusion injury
            Cardiology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00395-017-0657-7/MediaObjects/395_2017_657_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00395-017-0657-7/MediaObjects/395_2017_657_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00395-017-0657-7/MediaObjects/395_2017_657_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00395-017-0657-7/MediaObjects/395_2017_657_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00395-017-0657-7/MediaObjects/395_2017_657_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00395-017-0657-7/MediaObjects/395_2017_657_Fig6_HTML.gif
         isPartOf:
            name:Basic Research in Cardiology
            issn:
               1435-1803
               0300-8428
            volumeNumber:112
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Xavier Rossello
               affiliation:
                     name:University College London
                     address:
                        name:The Hatter Cardiovascular Institute, University College London, London, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jaime A. Riquelme
               affiliation:
                     name:University College London
                     address:
                        name:The Hatter Cardiovascular Institute, University College London, London, UK
                        type:PostalAddress
                     type:Organization
                     name:Universidad de Chile
                     address:
                        name:Advanced Center for Chronic Diseases (ACCDiS), Facultad de Ciencias Quimicas y Farmaceuticas and Facultad de Medicina, Universidad de Chile, Santiago, Chile
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zhenhe He
               affiliation:
                     name:University College London
                     address:
                        name:The Hatter Cardiovascular Institute, University College London, London, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Stasa Taferner
               affiliation:
                     name:University College London
                     address:
                        name:The Hatter Cardiovascular Institute, University College London, London, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Bart Vanhaesebroeck
               affiliation:
                     name:University College London
                     address:
                        name:UCL Cancer Institute, University College London, London, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sean M. Davidson
               affiliation:
                     name:University College London
                     address:
                        name:The Hatter Cardiovascular Institute, University College London, London, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Derek M. Yellon
               affiliation:
                     name:University College London
                     address:
                        name:The Hatter Cardiovascular Institute, University College London, London, UK
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:The role of PI3Kα isoform in cardioprotection
      description:Ischemic preconditioning (IPC) limits myocardial infarct size through the activation of the PI3K–Akt signal cascade; however, little is known about the roles of individual PI3K isoforms in cardioprotection. We aimed, therefore, to elucidate the role of the PI3Kα isoform in cardioprotection Pharmacological PI3Kα inhibition was assessed in isolated-perfused mouse hearts subjected to ischemia/reperfusion injury (IRI), either during the IPC procedure or at reperfusion. PI3Kα inhibition abrogated the IPC-induced protective effect at reperfusion, but not when given only during the IPC protocol. These results were confirmed in an in vivo model. Moreover, pharmacological PI3Kα activation by insulin at reperfusion was sufficient to confer cardioprotection against IRI. In addition, PI3Kα was shown to be expressed and activated in mouse cardiomyocytes, mouse cardiac endothelial cells, as well as in mouse and human heart tissue. Furthermore, PI3Kα was shown to mediate its effect though the inhibition of mitochondrial permeability transition pore opening. In conclusion, PI3Kα activity is required during the early reperfusion phase to reduce myocardial infarct size. This suggests that strategies specifically enhancing the α isoform of PI3K at reperfusion promote tissue salvage and as such, and could provide a direct target for clinical treatment of IRI.
      datePublished:2017-10-17T00:00:00Z
      dateModified:2017-10-17T00:00:00Z
      pageStart:1
      pageEnd:17
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1007/s00395-017-0657-7
      keywords:
         Cardioprotection
         Phosphoinositide 3-kinase
         Ischemic preconditioning
         Ischemia/reperfusion injury
         Cardiology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00395-017-0657-7/MediaObjects/395_2017_657_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00395-017-0657-7/MediaObjects/395_2017_657_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00395-017-0657-7/MediaObjects/395_2017_657_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00395-017-0657-7/MediaObjects/395_2017_657_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00395-017-0657-7/MediaObjects/395_2017_657_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00395-017-0657-7/MediaObjects/395_2017_657_Fig6_HTML.gif
      isPartOf:
         name:Basic Research in Cardiology
         issn:
            1435-1803
            0300-8428
         volumeNumber:112
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Xavier Rossello
            affiliation:
                  name:University College London
                  address:
                     name:The Hatter Cardiovascular Institute, University College London, London, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jaime A. Riquelme
            affiliation:
                  name:University College London
                  address:
                     name:The Hatter Cardiovascular Institute, University College London, London, UK
                     type:PostalAddress
                  type:Organization
                  name:Universidad de Chile
                  address:
                     name:Advanced Center for Chronic Diseases (ACCDiS), Facultad de Ciencias Quimicas y Farmaceuticas and Facultad de Medicina, Universidad de Chile, Santiago, Chile
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zhenhe He
            affiliation:
                  name:University College London
                  address:
                     name:The Hatter Cardiovascular Institute, University College London, London, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Stasa Taferner
            affiliation:
                  name:University College London
                  address:
                     name:The Hatter Cardiovascular Institute, University College London, London, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Bart Vanhaesebroeck
            affiliation:
                  name:University College London
                  address:
                     name:UCL Cancer Institute, University College London, London, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sean M. Davidson
            affiliation:
                  name:University College London
                  address:
                     name:The Hatter Cardiovascular Institute, University College London, London, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Derek M. Yellon
            affiliation:
                  name:University College London
                  address:
                     name:The Hatter Cardiovascular Institute, University College London, London, UK
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Basic Research in Cardiology
      issn:
         1435-1803
         0300-8428
      volumeNumber:112
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University College London
      address:
         name:The Hatter Cardiovascular Institute, University College London, London, UK
         type:PostalAddress
      name:University College London
      address:
         name:The Hatter Cardiovascular Institute, University College London, London, UK
         type:PostalAddress
      name:Universidad de Chile
      address:
         name:Advanced Center for Chronic Diseases (ACCDiS), Facultad de Ciencias Quimicas y Farmaceuticas and Facultad de Medicina, Universidad de Chile, Santiago, Chile
         type:PostalAddress
      name:University College London
      address:
         name:The Hatter Cardiovascular Institute, University College London, London, UK
         type:PostalAddress
      name:University College London
      address:
         name:The Hatter Cardiovascular Institute, University College London, London, UK
         type:PostalAddress
      name:University College London
      address:
         name:UCL Cancer Institute, University College London, London, UK
         type:PostalAddress
      name:University College London
      address:
         name:The Hatter Cardiovascular Institute, University College London, London, UK
         type:PostalAddress
      name:University College London
      address:
         name:The Hatter Cardiovascular Institute, University College London, London, UK
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Xavier Rossello
      affiliation:
            name:University College London
            address:
               name:The Hatter Cardiovascular Institute, University College London, London, UK
               type:PostalAddress
            type:Organization
      name:Jaime A. Riquelme
      affiliation:
            name:University College London
            address:
               name:The Hatter Cardiovascular Institute, University College London, London, UK
               type:PostalAddress
            type:Organization
            name:Universidad de Chile
            address:
               name:Advanced Center for Chronic Diseases (ACCDiS), Facultad de Ciencias Quimicas y Farmaceuticas and Facultad de Medicina, Universidad de Chile, Santiago, Chile
               type:PostalAddress
            type:Organization
      name:Zhenhe He
      affiliation:
            name:University College London
            address:
               name:The Hatter Cardiovascular Institute, University College London, London, UK
               type:PostalAddress
            type:Organization
      name:Stasa Taferner
      affiliation:
            name:University College London
            address:
               name:The Hatter Cardiovascular Institute, University College London, London, UK
               type:PostalAddress
            type:Organization
      name:Bart Vanhaesebroeck
      affiliation:
            name:University College London
            address:
               name:UCL Cancer Institute, University College London, London, UK
               type:PostalAddress
            type:Organization
      name:Sean M. Davidson
      affiliation:
            name:University College London
            address:
               name:The Hatter Cardiovascular Institute, University College London, London, UK
               type:PostalAddress
            type:Organization
      name:Derek M. Yellon
      affiliation:
            name:University College London
            address:
               name:The Hatter Cardiovascular Institute, University College London, London, UK
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:The Hatter Cardiovascular Institute, University College London, London, UK
      name:The Hatter Cardiovascular Institute, University College London, London, UK
      name:Advanced Center for Chronic Diseases (ACCDiS), Facultad de Ciencias Quimicas y Farmaceuticas and Facultad de Medicina, Universidad de Chile, Santiago, Chile
      name:The Hatter Cardiovascular Institute, University College London, London, UK
      name:The Hatter Cardiovascular Institute, University College London, London, UK
      name:UCL Cancer Institute, University College London, London, UK
      name:The Hatter Cardiovascular Institute, University College London, London, UK
      name:The Hatter Cardiovascular Institute, University College London, London, UK

External Links {🔗}(255)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Foundation
  • Prism.js

CDN Services {📦}

  • Crossref

5.01s.